Gerstner E - Search Results

1

Gerstner E, Batchelor T. Gerstner E, et al. Expert Rev Anticancer Ther. 2007 May;7(5):689-700. doi: 10.1586/14737140.7.5.689. Expert Rev Anticancer Ther. 2007. PMID: 17492932 Review.

2

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders.

Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB, Rosenfeld MR. Dalmau J, et al. Among authors: gerstner e. Brain. 1999 Jan;122 ( Pt 1):27-39. doi: 10.1093/brain/122.1.27. Brain. 1999. PMID: 10050892

3

Antiangiogenic agents for the treatment of glioblastoma.

Gerstner ER, Duda DG, di Tomaso E, Sorensen G, Jain RK, Batchelor TT. Gerstner ER, et al. Expert Opin Investig Drugs. 2007 Dec;16(12):1895-908. doi: 10.1517/13543784.16.12.1895. Expert Opin Investig Drugs. 2007. PMID: 18041999 Review.

4

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation.

Gerstner ER, Carson KA, Grossman SA, Batchelor TT. Gerstner ER, et al. Neurology. 2008 Jan 29;70(5):401-2. doi: 10.1212/01.wnl.0000300671.37279.0e. Neurology. 2008. PMID: 18227422 Free PMC article. Clinical Trial. No abstract available.

5

CNS Hodgkin lymphoma.

Gerstner ER, Abrey LE, Schiff D, Ferreri AJ, Lister A, Montoto S, Tsang R, Thiel E, Graus F, Behringer D, Illerhaus G, Weaver S, Wen P, Voloschin A, Harris NL, Batchelor TT. Gerstner ER, et al. Blood. 2008 Sep 1;112(5):1658-61. doi: 10.1182/blood-2008-04-151563. Epub 2008 Jun 30. Blood. 2008. PMID: 18591379 Free PMC article.

6

High-dose methotrexate for elderly patients with primary CNS lymphoma.

Zhu JJ, Gerstner ER, Engler DA, Mrugala MM, Nugent W, Nierenberg K, Hochberg FH, Betensky RA, Batchelor TT. Zhu JJ, et al. Neuro Oncol. 2009 Apr;11(2):211-5. doi: 10.1215/15228517-2008-067. Epub 2008 Aug 29. Neuro Oncol. 2009. PMID: 18757775 Free PMC article.

7

Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas.

Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Gerstner ER, et al. Curr Opin Neurol. 2008 Dec;21(6):728-35. doi: 10.1097/WCO.0b013e328318402a. Curr Opin Neurol. 2008. PMID: 18989120 Review.

8

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT. Gerstner ER, et al. Nat Rev Clin Oncol. 2009 Apr;6(4):229-36. doi: 10.1038/nrclinonc.2009.14. Nat Rev Clin Oncol. 2009. PMID: 19333229 Free PMC article. Review.

9

Anti-vascular endothelial growth factor therapy for malignant glioma.

Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Gerstner ER, et al. Curr Neurol Neurosci Rep. 2009 May;9(3):254-62. doi: 10.1007/s11910-009-0037-2. Curr Neurol Neurosci Rep. 2009. PMID: 19348715 Free PMC article. Review.

10

Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.

Gerstner ER, Yip S, Wang DL, Louis DN, Iafrate AJ, Batchelor TT. Gerstner ER, et al. Neurology. 2009 Nov 3;73(18):1509-10. doi: 10.1212/WNL.0b013e3181bf9907. Neurology. 2009. PMID: 19884580 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters